Company / Operating Cash Flow
MEDICINOVA INC Operating Cash Flow History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$9.8M
FY2025
5-year range
-$12.9M / -$7.4M
FY2021-FY2025
Trend
-32.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$13M to -$10M over the past 2 years.
Based on SEC 10-K filings.
-$10M in FY2025.
Improved from -$13M to -$10M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow decreased 32.0% year-over-year.
- Peak operating cash flow was recorded in FY2014.
- Lowest operating cash flow in the period was in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$9.8M | -32.0% |
| FY2024 | -$7.4M | +42.4% |
| FY2023 | -$12.9M | +0.0% |
| FY2022 | -$12.9M | -37.6% |
| FY2021 | -$9.4M | -1249.0% |
| FY2014 | $816.5K | +106.9% |
| FY2013 | -$11.9M | +10.9% |
| FY2012 | -$13.3M | +0.0% |
| FY2011 | -$13.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026